Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s Disease

americanpharmaceuticalreviewApril 09, 2021

Tag: ImmunoPrecise , TATX-112 , Talem

PharmaSources Customer Service